ArticleBMC cancer2022

Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells.

Wioleta Dudka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.